(Q34748787)

4 August 2017

1 reference

title

Transimmunization and the evolution of extracorporeal photochemotherapy (English)

1 reference

4 August 2017

Michael Girardi

1

1 reference

4 August 2017

Jeffrey Schechner

2

1 reference

4 August 2017

Earl Glusac

3

1 reference

4 August 2017

Carole Berger

4

1 reference

4 August 2017

Richard Edelson

5

1 reference

4 August 2017

1 June 2002

1 reference

Transfusion and Apheresis Science

4 August 2017

1 reference

4 August 2017

26

1 reference

4 August 2017

3

1 reference

4 August 2017

181-190

1 reference

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Photopheresis for the treatment of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Extracorporeal photopheresis in the treatment of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Photopheresis and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Renal allograft rejection controlled by photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Photopheresis for chronic rejection of lung allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Dendritic cells: specialized and regulated antigen processing machines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Induction of human tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900011-3

7 January 2021

10.1016/S1473-0502(02)00011-3

Identifiers

DOI

1 reference

4 August 2017

1 reference